Ribozymes as Tools for Therapeutic Target Validation in Arthritis
Thale C. Jarvis(Crestone (United States)), Craig M. Flory(University of Minnesota)
Cited by 16
Related Papers
Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets
|Proceedings of the National Academy of Sciences|2012|254
Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota
|Antimicrobial Agents and Chemotherapy|2019|38